Key Takeaways
- • Orrick achieved No. 3 global ranking for venture capital transactions in Q1 2026, according to PitchBook's league tables, while facilitating over $40 billion in venture capital financing for clients during the quarter.
- • The firm secured its 10th consecutive year as the No. 1 legal advisor to Europe's venture capital ecosystem, reinforcing its dominant position across the continent and signaling sustained deal flow momentum in the region.
- • Orrick ranked No. 1 globally for healthcare services and systems transactions in Q1 2026, reflecting strategic focus on life sciences and healthtech sectors amid broader venture market activity.
- • Geographic performance shows concentrated strength in Europe (No. 1), with additional presence at No. 4 in the United States venture capital rankings, demonstrating a bifurcated geographic advantage.
- • The firm's leadership position is grounded in advisory work across all growth stages, with documented analysis of 400+ venture and growth equity investments completed by Orrick clients across Europe in 2025.
Summary
Orrick maintained its position among the world's leading venture capital legal advisors in Q1 2026, securing third place globally in PitchBook's quarterly league tables while extending a decade-long dominance in European venture markets. The firm facilitated more than $40 billion in venture capital financing for clients during the first quarter, according to the firm's own announcement, reflecting substantial deal flow across its global platform.
The firm's geographic rankings reveal concentrated strength in specific markets. Orrick held the No. 1 position in Europe for venture capital deal work—a distinction it has maintained consecutively for ten years—while ranking No. 4 in the United States venture capital transactions. This European leadership underscores the firm's strategic positioning as the primary legal counsel to the region's venture capital ecosystem, a market segment where it has achieved consistent top-tier recognition.
Beyond traditional venture rankings, Orrick achieved the No. 1 global position for healthcare services and systems transactions in Q1 2026, reflecting deliberate sectoral focus on life sciences and healthtech verticals. This ranking suggests the firm has successfully differentiated its practice in high-growth, capital-intensive sectors that command premium legal advisory engagement.
The foundation for these rankings appears grounded in documented deal activity. Orrick's analysis of venture and growth equity investments closed by its clients in 2025 covered more than 400 transactions across European markets, indicating substantial market penetration and repeating client relationships. This deal volume across multiple European jurisdictions—including operations in Germany and Italy cited within organizational materials—provides the scale necessary to sustain top-tier league table positions.
The results position Orrick as a cornerstone advisor to the venture capital ecosystem during a period when institutional capital continues to flow toward innovation-stage companies, particularly in health sciences and technology sectors. The firm's sustained top-three global ranking and unbroken European leadership suggest client confidence in its capability to navigate complex equity financings across multiple jurisdictions and growth stages.
The firm's geographic rankings reveal concentrated strength in specific markets. Orrick held the No. 1 position in Europe for venture capital deal work—a distinction it has maintained consecutively for ten years—while ranking No. 4 in the United States venture capital transactions. This European leadership underscores the firm's strategic positioning as the primary legal counsel to the region's venture capital ecosystem, a market segment where it has achieved consistent top-tier recognition.
Beyond traditional venture rankings, Orrick achieved the No. 1 global position for healthcare services and systems transactions in Q1 2026, reflecting deliberate sectoral focus on life sciences and healthtech verticals. This ranking suggests the firm has successfully differentiated its practice in high-growth, capital-intensive sectors that command premium legal advisory engagement.
The foundation for these rankings appears grounded in documented deal activity. Orrick's analysis of venture and growth equity investments closed by its clients in 2025 covered more than 400 transactions across European markets, indicating substantial market penetration and repeating client relationships. This deal volume across multiple European jurisdictions—including operations in Germany and Italy cited within organizational materials—provides the scale necessary to sustain top-tier league table positions.
The results position Orrick as a cornerstone advisor to the venture capital ecosystem during a period when institutional capital continues to flow toward innovation-stage companies, particularly in health sciences and technology sectors. The firm's sustained top-three global ranking and unbroken European leadership suggest client confidence in its capability to navigate complex equity financings across multiple jurisdictions and growth stages.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.